Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Jorge Vela"'
Autor:
Eduardo Fuentes, Carlos Gómez, Dante Pizarro, Julio Alegre, Miguel Castillo, Jorge Vela, Ethel Huaman, Héctor Vásquez
Publikováno v:
Tropical Grasslands-Forrajes Tropicales, Vol 10, Iss 2, Pp 78-88 (2022)
Livestock in the Peruvian Amazon region is mostly produced in areas considered degraded pastureland and associated with deforestation. Silvopastoral systems (SPS) are an alternative for sustainable livestock production. This article aims to provide i
Externí odkaz:
https://doaj.org/article/0f8329bca3a44289b850e98aeb69e90f
Autor:
Patricia Gómez-Rosas, Miguel Á. Sosa-Velázquez, Lesly A. Yáñez-Funes, José J. González-Trejo, Karim Majluf-Cruz, Irma Isordia-Salas, Gregorio Ignacio-Ibarra, Martín Almaraz-Delgado, Luis A. Moreno-Ruiz, Jesús S. Valencia-Chávez, Jesús Hernández-Juárez, David Vázquez-Rubiel, Víctor Domínguez-Reyes, Rodrigo Arreola-Díaz, Ma. Teresa García-Lee, Jorge Vela-Ojeda, Abraham Majluf-Cruz
Publikováno v:
Gaceta Médica de México, Vol 157, Iss 3 (2021)
Externí odkaz:
https://doaj.org/article/3b03193522cc4f9fa6e7c2bd8e556316
Autor:
Vania Tietsche de Moraes Hungria, Carlos Chiattone, Miguel Pavlovsky, Lina M. Abenoza, Gladys P. Agreda, Jorge Armenta, Celso Arrais, Oscar Avendaño Flores, Fernando Barroso, Ana L. Basquiera, Carmen Cao, Maria S. Cugliari, Alicia Enrico, Laura M. Foggliatto, Kenny M. Galvez, David Gomez, Alvaro Gomez, Daniel de Iracema, Danielle Farias, Lineth Lopez, William Armando Mantilla, Deborah Martínez, Maria Jose Mela, Carlos E. Miguel, Roberto Ovilla, Luis Palmer, Carolina Pavlovsky, Christian Ramos, Guillermina Remaggi, Rodrigo Santucci, Sergio Schusterschitz, Claudia Lucia Sossa, Elena Tuna-Aguilar, Jorge Vela, Telma Santos, Odin de la Mora, Gerardo Machnicki, Mariana Fernandez, Paula Barreyro
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-19 (2019)
PURPOSE: Limited information is available on multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma (NHL) management in Latin America. The primary objective of the Hemato-Oncology Latin America (HOLA) study was to describ
Externí odkaz:
https://doaj.org/article/e1cf84fea5fb415293927848125b0db5
Autor:
Martha R. Vieyra-Lobato, Jorge Vela-Ojeda, Laura Montiel-Cervantes, Rubén López-Santiago, Martha C. Moreno-Lafont
Publikováno v:
Journal of Immunology Research, Vol 2018 (2018)
Gershon and Kondo described CD8+ Treg lymphocytes as the first ones with regulating activity due to their tolerance ability to foreign antigens and their capacity to inhibit the proliferation of other lymphocytes. Regardless, CD8+ Treg lymphocytes ha
Externí odkaz:
https://doaj.org/article/2f997cd702894bf4afd0fbdb7f0c5c86
Autor:
Alberto Ponciano-Gómez, Adolfo Martínez-Tovar, Jorge Vela-Ojeda, Irma Olarte-Carrillo, Federico Centeno-Cruz, Efraín Garrido
Publikováno v:
Tumor Biology, Vol 39 (2017)
Acute myeloid leukemia is characterized by its high biological and clinical heterogeneity, which represents an important barrier for a precise disease classification and accurate therapy. While epigenetic aberrations play a pivotal role in acute myel
Externí odkaz:
https://doaj.org/article/6de125b3938d46c9b9bd464ae21c8dd8
Autor:
Adriana Gutiérrez-Hoya, Rubén López-Santiago, Jorge Vela-Ojeda, Laura Montiel-Cervantes, Octavio Rodríguez-Cortés, Víctor Rosales-García, Vladimir Paredes-Cervantes, Raúl Flores-Mejía, Daniela Sandoval-Borrego, Martha Moreno-Lafont
Publikováno v:
Journal of Immunology Research, Vol 2017 (2017)
CD8+ T cells that secrete proinflammatory cytokines play a central role in exacerbation of inflammation; however, a new subpopulation of CD8 regulatory T cells has recently been characterized. This study analyzes the prominent role of these different
Externí odkaz:
https://doaj.org/article/43024d45af274b5dbb90a2904c794c55
Autor:
Neil P. Shah, Dong-Wook Kim, Hagop Kantarjian, Philippe Rousselot, Pedro Enrique Dorlhiac Llacer, Alicia Enrico, Jorge Vela-Ojeda, Richard T. Silver, Hanna Jean Khoury, Martin C. Müller, Alexandre Lambert, Yousif Matloub, Andreas Hochhaus
Publikováno v:
Haematologica, Vol 95, Iss 2 (2010)
Background Dasatinib 100 mg once daily achieves intermittent BCR-ABL kinase inhibition and is approved for chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib. To better assess durability of response to and tolerabilit
Externí odkaz:
https://doaj.org/article/59de562051b644a4af292ce3f5312de9
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S361-S361
Autor:
Michael A. Thompson, Mario Boccadoro, Xavier Leleu, Jorge Vela-Ojeda, Frits van Rhee, Katja C. Weisel, Robert M. Rifkin, Saad Z. Usmani, Roman Hájek, Gordon Cook, Rafat Abonour, Mira Armour, Kathryn E. Morgan, Su-Peng Yeh, Caitlin L. Costello, Jesus G. Berdeja, Faith E. Davies, Jeffrey A. Zonder, Hans C. Lee, Jim Omel, Andrew Spencer, Evangelos Terpos, Vania T.M. Hungria, Noemi Puig, Chengcheng Fu, Renda H. Ferrari, Kaili Ren, Dawn Marie Stull, Ajai Chari
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 23:e171-e181
Autor:
Noemi Puig, Vania T.M. Hungria, Ajai Chari, Faith E. Davies, Gordon Cook, Roman Hájek, Kathryn E. Morgan, Jim Omel, Evangelos Terpos, Michael A. Thompson, Saad Usmani, Jorge Vela-Ojeda, Katja Weisel, Mira Armour, Kaili Ren, Dasha Cherepanov, Dawn Marie Stull, Jesus Berdeja
Publikováno v:
Blood. 140:4269-4272